Vinorelbine (NVB)-based triplet with ifosfamide (IFO) and cisplatin (NIP) as induction chemotherapy (CT) to increase resection rate in marginally unresectable non-small cell lung cancer (NSCLC) patients (pts)
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7165-7165
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7165-7165
Keyword(s):
2005 ◽
Vol 23
(16_suppl)
◽
pp. 7354-7354
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7142-7142
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7142-7142
Keyword(s):
Keyword(s):